YCM
LGND icon

Yousif Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History

Yousif Capital Management’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.72M Buy
5,451
+88
+2% +$20.7K 0.02% 760
2026
Q1 		$1.07M Sell
5,363
-39
-0.7% -$7.72K 0.01% 1019
2025
Q4 		$1.06M Sell
5,402
-752
-12% -$144K 0.01% 1050
2025
Q3 		$1.09M Sell
6,154
-1,128
-15% -$168K 0.01% 1056
2025
Q2 		$828K Buy
7,282
+270
+4% +$28.9K 0.01% 1232
2025
Q1 		$737K Sell
7,012
-181
-3% -$20.5K 0.01% 1265
2024
Q4 		$771K Buy
7,193
+96
+1% +$10.9K 0.01% 1289
2024
Q3 		$710K Buy
7,097
+316
+5% +$31.8K 0.01% 1345
2024
Q2 		$571K Sell
6,781
-665
-9% -$52.9K 0.01% 1408
2024
Q1 		$544K Sell
7,446
-745
-9% -$54.9K 0.01% 1478
2023
Q4 		$585K Buy
8,191
+50
+0.6% +$2.95K 0.01% 1467
2023
Q3 		$488K Sell
8,141
-570
-7% -$37.5K 0.01% 1496
2023
Q2 		$628K Sell
8,711
-357
-4% -$26.8K 0.01% 1390
2023
Q1 		$667K Sell
9,068
-1,245
-12% -$88.5K 0.01% 1345
2022
Q4 		$689K Sell
10,313
-11,605
-53% -$755K 0.01% 1359
2022
Q3 		$1.18M Sell
21,918
-1,308
-6% -$76.9K 0.02% 1085
2022
Q2 		$1.29M Sell
23,226
-2,156
-8% -$122K 0.02% 1095
2022
Q1 		$1.78M Buy
25,382
+361
+1% +$26.2K 0.02% 1024
2021
Q4 		$2.41M Buy
+25,021
New +$2.31M 0.02% 842

Other funds holding LGND

CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
WC
Woodstock Corp Boston, Massachusetts $1.2B AUM 26.37% 1-Year Est. Return
MNBTD
Moody National Bank Trust Division Galveston, Texas $1.21B AUM 38.93% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LTAS
Linden Thomas Advisory Services Charlotte, North Carolina $1.24B AUM 47.37% 1-Year Est. Return
TAM
Tealwood Asset Management Minneapolis, Minnesota $261M AUM 52.68% 1-Year Est. Return
PWG
Portside Wealth Group Provo, Utah $858M AUM 26.82% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
KPP
Kings Path Partners Sugar Land, Texas $376M AUM 19% 1-Year Est. Return

Yousif Capital Management's LGND Position: Q2 2026 in Review

Yousif Capital Management increased its Ligand Pharmaceuticals (LGND) stake by 1.6% in Q2 2026, buying an estimated $20.7K and bringing the position to 5,451 shares worth $1.72M. The position accounts for 0.02% of the portfolio, ranked #760.

Yousif Capital Management first reported a position in LGND in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.41M in Q4 2021. 36 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • Yousif Capital Management held 5,451 shares of Ligand Pharmaceuticals worth $1.72M as of Q2 2026.
  • Yousif Capital Management bought 88 Ligand Pharmaceuticals shares in Q2 2026, an estimated $20.7K.
  • Ligand Pharmaceuticals made up 0.02% of Yousif Capital Management's portfolio in Q2 2026, its #760 holding.
  • Yousif Capital Management first reported a position in Ligand Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • Yousif Capital Management's Ligand Pharmaceuticals position peaked at $2.41M in Q4 2021.
  • 36 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Yousif Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.